This session will provide up to date spatial and single cell transcriptomics during liver disease characterized by hepatic fibrosis. AI tools will be discussed with regards to identifying potential therapeutic targets.

We will share the top tips to help liver disease patients optimize their health and well-being.

This session will describe state-of-the-art omic techniques to characterize cholangiocytes biology in various liver diseases.

In this session the learner will be exposed to and gain a better understanding of the role that organoids may play in elucidating disease phenotypes and signaling mechanisms. Both hepatic and bile-derived organoids will be covered in relation to hepatic f

This session will provide patients, caregivers, and healthcare professionals with a comprehensive understanding of MASLD and its impact on patients' lives. The session will feature patient testimonials, expert presentations, and interactive discussions ai

This session is designed to provide patients, caregivers, and healthcare professionals with a comprehensive understanding of liver cancer and its impact on patients' lives. The session will feature patient testimonials, expert presentations, and interacti

Is Palliative Care and Hospice the same thing?  As a chronic liver disease or end-stage liver patient how can focusing on frailty and palliative care actually improve patient outcomes? Palliative Care provides excellent resources for patients and their ca

Every provider and patient communicate differently. During this program we will discuss ways to relay patient wants/needs to the provider; while also making sure the provider is able to educate the patient/caregiver. We will be sharing examples of pre-app

In this session learners will gain a better understanding of the role of innate immunity and innate immune cells in the regulation of hepatic fibrosis. The paracrine role of innate immune cells with fibrogenic cells and potential therapeutic interventions